|
0
|
|
Advances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental priorities.
(linkinghub.elsevier.com)
|
Walzl G
…
Zumla A
Lancet Microbe
2027 Apr 27
|
#tb
#diagnostics
#amr
#biomarker
#molecular
|
|
0
|
|
Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access.
(linkinghub.elsevier.com)
|
da Costa C
…
Zumla A
Lancet Microbe
2027 Apr 26
|
#tb
#vaccination
#chemotherapy
#clinical-trials
#immunotherapy
|
|
0
|
|
Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines.
(linkinghub.elsevier.com)
|
Marais BJ
…
Zumla A
Lancet Microbe
2027 Apr 26
|
#tb
#amr
#therapeutics
#clinical-trials
#hiv
|
|
0
|
|
State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges.
(linkinghub.elsevier.com)
|
Zenner D
…
Zumla A
Lancet Microbe
2027 Apr 26
|
#tb
#epidemiology
#hiv
#diagnostics
#infection
|
|
0
|
|
Adaptive immunity shapes baseline physiology of M. tuberculosis in high-dose versus low-dose infection BALB/c mouse drug treatment models.
(journals.asm.org)
|
Hendrix J
…
Walter ND
Antimicrobial Agents and Chemotherapy
2026-07-31
|
#tb
#immunity
#drug efficacy
#transcriptomics
#pathogenesis
|
|
0
|
|
Human risk factors associated with the presence of antibodies against Mycobacterium tuberculosis complex in captive Asian elephants from Chitwan valley, Nepal.
(linkinghub.elsevier.com)
|
Rajbhandari RM
…
Gortazar C
One Health
2026-07-31
|
#tb
#zoonosis
#epidemiology
#serology
#biosecurity
|